companydata.dkcompanydata.dk

MEDIPURE SCANDINAVIA A/S: Financial statements 2020

CVR: 13275149

Source: annual report 2020, Danish Business Authority

01/07/2019 – 30/06/2020

MEDIPURE SCANDINAVIA A/S (CVR 13275149) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -181,848 and a net result of DKK -241,516 compared with DKK 79,907 the year before. Equity in the 2020 report amounted to DKK 1,179,883. The solvency ratio was 98.2%.

Gross Profit
DKK -181,848
Profit/Loss
DKK -241,516
Equity
DKK 1,179,883
Total Assets
DKK 1,201,258

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020--182K-242K1.2M-
2019-109K80K1.4M-
2018--66K-112K1.6M-
2017-269K158K1.8M-
2016-89K90K1.6M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is MEDIPURE SCANDINAVIA A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About MEDIPURE SCANDINAVIA A/S

MEDIPURE SCANDINAVIA A/S was a Danish company of the type Aktieselskab based in Risskov, founded in 1989. The company has been dissolved on 12 November 2025. The company was registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named BAXA INTERNATIONAL ApS and ASX 14709 ApS. The company has 1 employee (2009). In 2024, the company reported a gross profit of DKK -24,760 and a net result of DKK -4,255 compared with DKK -5,675 the year before. Equity in the 2024 report amounted to DKK 789,098.

Source: annual report 2024, Danish Business Authority